INmune Bio

FDA lifts clinical hold on INmune Bio’s Phase II Alzheimer’s trial
Clinical Trials Arena
Tue, 01/30/24 - 09:19 pm
INmune Bio
clinical trials
Alzheimer's disease
Xpro
FDA
Four Potential Biotech Market Movers to Watch Going into 2021
BioSpace
Fri, 12/18/20 - 10:59 am
INmune Bio
Valneva
CalciMedica
Vaxart
vaccines
COVID-19
pandemic